国际肝胆健康（英文）Issue(4)：20-22,3.DOI:10.1016/j.iliver.2025.100198
DGKH-PA-mTOR:A pharmacologically druggable metabolic axis underpinning tyrosine-kinase-inhibitor resistance in hepatocellular carcinoma
DGKH-PA-mTOR:A pharmacologically druggable metabolic axis underpinning tyrosine-kinase-inhibitor resistance in hepatocellular carcinoma
Feifan Cai 1Bixing Zhao2
作者信息
- 1. The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province,Mengchao Hepatobiliary Hospital of Fujian Medical University,Fuzhou 350025,Fujian,China
- 2. College of Biological Science and Engineering,Fuzhou University,Fuzhou 350108,Fujian,China
- 折叠
引用本文复制引用
Feifan Cai,Bixing Zhao..DGKH-PA-mTOR:A pharmacologically druggable metabolic axis underpinning tyrosine-kinase-inhibitor resistance in hepatocellular carcinoma[J].国际肝胆健康（英文）,2025,(4):20-22,3.
